Barclays
GEVA

Barclays’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Barclays’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$1.93M Buy
2014
Q4 		$196K Sell
2014
Q3 		$321K Sell
2014
Q2 		$1.05M Buy
2014
Q1 		$504K Sell
2013
Q4 		$514K Sell
2013
Q3 		$617K Buy
2013
Q2 		$95K Buy